This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ties May Bind Apple's CEO to Board

During the 16-month period between 2000 and 2001, Drexler and the rest of Apple's board essentially acted as the company's compensation committee. This would call into question Jobs' independence from Drexler under current marketplace rules.

Moreover, from the time Jobs rejoined Apple until August 2001, the board of directors had no nominating committee, meaning that no formal process independent of Jobs existed to nominate and consider new board candidates.

Not only did Drexler join the board during that time period, so did Arthur Levinson, the CEO of Genentech (GENE). (A Genentech representative said that Levinson wasn't available for comment.)

Such ties and process problems are reason to question the independence of Apple's board at the time, says the CII's Ellsworth. And the lack of an independent board is a red flag that can signal other trouble, she said.

Referring to the wider scandal involving companies that are deceptively manipulating the grant dates and strike prices of stock options, Ellsworth says, "We're going to hear a lot more about the [options] backdating and cozy boards."

Apple finished trading Wednesday down $1.45, or 2%, at $70.03.
5 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
GENE $2.08 1.50%
INTU $90.06 -0.95%
ORCL $35.09 -1.50%
AAPL $95.01 0.00%
FB $99.51 -0.24%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs